1 / 3

Suppl.Fig.1

PBMCs. 1.8%. 90%. FS. count. count. SS. control ab-FITC. A. HCVcore-FITC. CD8-ECD. CD8-PE. CD4-PE. CD4. CD8. HCVcore-FITC. HCVcore-FITC. HCVcore-FITC. CD4-PE. M. 49.6%. K. 31.7%. K. M. M. K. HCVcore-FITC. 99.8%. 99.7%. count. count. 48%. 65.4%. B. HCVcore-FITC.

hawa
Download Presentation

Suppl.Fig.1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PBMCs 1.8% 90% FS count count SS control ab-FITC A. HCVcore-FITC CD8-ECD CD8-PE CD4-PE CD4 CD8 HCVcore-FITC HCVcore-FITC HCVcore-FITC CD4-PE M 49.6% K 31.7% K M M K HCVcore-FITC 99.8% 99.7% count count 48% 65.4% B. HCVcore-FITC HCVcore-FITC IHLs 62.6% 3.22% count count FS C. HCVcore-FITC control ab-FITC SS CD8 CD4 23.7% D E 96.2% 90% 19.2% E D E Suppl.Fig.1 count count 39.7% 43.1% D. HCVcore-FITC HCVcore-FITC

  2. t.p.inc. t.p.inc. C. A. Suppl.Fig. 2 t.p.inc B.

  3. t.p.inc. t.p.inc. C. A. D. t.p.inc. t.p.inc. B. Suppl.Fig. 3

More Related